Journal scan

Macular degeneration

Age-related macular degeneration is the leading cause of blindness in people over 50.

Gene therapy may reduce macular degeneration

Picture credit: Science Photo Library

A main feature of the disease is the presence of lipid-rich deposits underneath the retinal pigmented epithelium. Although these deposits do not affect vision they act as a focus for the atrophy of retinal cells and the proliferation of new blood vessels in the underlying choroid.

Reducing the lipid burden without damaging the retina or encouraging new vessels would be desirable. Previous interventions, such as laser to reduce the lipid deposits, have been unsuccessful but new breakthroughs could be near.

Genome studies have shown multiple genes involved in cholesterol homeostasis. It may be possible to use the recently discovered microRNA molecules to decrease cholesterol synthesis and enhance reverse cholesterol transport from the retina to the liver.

Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Nursing Older People
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?